title: Reply: To PMID 24315859.
authors.affiliation: Kelsey-Seybold Clinic, Department of Obstetrics & Gynecology, Houston, TX; Baylor College of Medicine, Department of Obstetrics & Gynecology, Houston, TX; UT Health, The University of Texas Medical School at Houston, Department of Obstetrics, Gynecology, and Reproductive Sciences, Houston, TX. Electronic address: Mark.Turrentine@Kelsey-Seybold.com.
authors.forename: Mark
authors.initials: M
authors.lastname: Turrentine
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D019072:Antibiotic Prophylaxis / Q000379:methods*; D005260:Female; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D018805:Sepsis / Q000517:prevention & control*; D013290:Streptococcal Infections / Q000517:prevention & control*; D013292:Streptococcus agalactiae
chemical_list: D000900:Anti-Bacterial Agents